UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): May 25, 2016

 

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

     
New York 0-16093 16-0977505
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)

 

 

 

525 French Road

Utica, New York 13502

(Address of principal executive offices, including zip code)

 

 

 

(315) 797-8375

(Registrant's telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

o          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

The annual meeting of shareholders of CONMED Corporation was held on May 25, 2016 (the “Annual Meeting”). Holders of Common Stock were entitled to elect ten directors. On all matters which came before the Annual Meeting, holders of Common Stock were entitled to one vote for each share held. Proxies for 26,664,125 of the 27,751,244 shares of Common Stock entitled to vote were received in connection with the Annual Meeting.

 

The following table sets forth the names of the ten persons elected at the Annual Meeting to serve as directors until the first annual meeting of shareholders following the end of the Company’s fiscal year ending December 31, 2016 and the number of votes cast for, against or withheld with respect to each person.

 

Election of Directors

 

Director Votes Received Votes Withheld Broker Non-Votes
       
David Bronson 25,147,055   546,603 970,467
Brian P. Concannon 25,144,347   549,311 970,467
Charles M. Farkas 24,991,942   701,716 970,467
Martha Goldberg Aronson 25,145,331   548,327 970,467
Jo Ann Golden 24,984,345   709,313 970,467
Curt R. Hartman 25,146,698   546,960 970,467
Dirk M. Kuyper 24,981,475   712,183 970,467
Jerome J. Lande 24,983,428   710,230 970,467
Mark E. Tryniski 25,135,626   558,032 970,467
John L. Workman 25,158,602   535,056 970,467

 

 

Management Proposals

 

  For Against Abstain Broker
Non-Votes
Ratification of the appointment of PricewaterhouseCoopersLLP as independent registered public accounting firm for the Company for the fiscal year ending December 31, 2016 26,193,107 462,394   8,624 —
         
Approve advisory vote on Named Executive Officer compensation 24,602,830  782,172 308,656 970,467
         
Approve the Amended and Restated 2016 Non-Employee Director Equity Compensation Plan 17,076,509 8,275,240 341,909 970,467

 

 

 

 

Item 8.01 Other Events

 

On May 25, 2016, CONMED Corporation announced it will be paying a quarterly cash dividend of $0.20 per share on July 6, 2016 to all shareholders of record as of June 15, 2016.

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

          CONMED CORPORATION
                      (Registrant)
       
  By:   /s/ Luke A. Pomilio
  Name:   Luke A. Pomilio
  Title:   Executive Vice President –
Finance and Chief Financial Officer

 

Date: May 25, 2016